CELL-SIGNALING-TECH/DAKO
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology (CST), a worldwide provider of antibodies, today announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products.
"We are pleased to work with CST in the development of high-quality, cutting-edge companion diagnostic products that will be an important tool in the diagnosis and treatment of cancer," said Jacob Thaysen, president of Agilent's Diagnostics and Genomics Group.
The market for companion diagnostics is steadily growing, as personalized medicine may improve patient care and assist in managing healthcare costs by targeting treatments to individuals more likely to benefit from specific therapies, particularly in the treatment of cancer.
Today’s announcement follows several other collaborative agreements in the companion diagnostics area. Agilent’s Dako business has a record of successful long-term partnerships with companies such as Pfizer, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Amgen and Eli Lilly, and it continues to attract new partners.
“CST recognizes that companion diagnostic products have great potential to improve the way we diagnose and treat patients with cancer,” said Michael J. Comb , CEO of CST. “We believe this partnership will allow our products to contribute to the advancement of personalized medicine.”
The financial details of the agreement were not disclosed.
About Cell Signaling Technologies
Founded by research scientists in 1999, CST is a private, family-owned company with over 400 employees worldwide. Active in the field of applied systems biology research, particularly as it relates to cancer, CST understands the importance of using antibodies with high levels of specificity and lot-to-lot consistency. We produce all of our antibodies in house, and perform painstaking validations for multiple applications. Technical support is provided by the same CST scientists who produce our antibodies, helping customers design experiments, troubleshoot, and achieve reliable results. CST is certified by BSI to be compliant with ISO 9001:2008 for the design, development, and production of monoclonal antibodies. Information about CST is available at www.cellsignal.com .
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. Agilent generated revenues of $4.0 billion in fiscal 2014. The company employs about 12,000 people worldwide. In 2012, Agilent acquired Dako, a well-known provider of reagents, instruments, software and expertise to make accurate diagnoses and determine the most effective treatment for cancer patients. Information about Agilent is available at www.agilent.com and information about Dako products is available at www.dako.com .
Cell Signaling Technology® , and CST™ are trademarks of Cell Signaling Technology, Inc.
Contact:
Agilent
Maia Fredtoft Søchting, +45 2546 1083
maia.sochting@agilent.com
or
Cell
Signaling Technology, Inc.
Rebecca J. Reppucci, MBA, +1 978-867-2382
Director
of Marketing Communications
marketingpr@cellsignal.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Citi and Ant International Pilot AI-Enabled Forecasting Solution to Enhance FX Risk Management for Airline Customers18.7.2025 04:30:00 CEST | Press release
Ant International’s Falcon TST Model will give Citi’s clients an improved FX risk management solution when selling through e-commerce channels.Pilot airline customer of the jointly-developed solution has already seen a cost reduction in their Fixed FX Rates hedging programme for online ticket sales. Citi and Ant International announced today that they are piloting the use of Ant International's Falcon Time-Series Transformer (TST) Model to deliver an enhanced FX risk management solution for their customers. Developed with aviation clients as an initial use case, the solution aims to offer greater payment solutions for the airline industry, which processes billions of payment transactions annually. With airline travel set to continue growing, the joint solution combines Ant International's experience with airline payments and Citi's robust FX solutions to help the bank's clients manage their FX costs more efficiently. Ant International’s Falcon TST Model is a transformer architecture-ba
AGC Launches Innovative Fluoroelastomer Without the Use of Surfactants or Fluorinated Polymerization Solvents18.7.2025 04:00:00 CEST | Press release
AGC (AGC Inc., Headquarters: Tokyo; President: Yoshinori Hirai)(TOKYO:5201), a world-leading manufacturer of glass, chemicals and other high-tech materials, proudly announces the launch of surfactant and fluorinated polymerization solvent free grades in its fluoroelastomer “AFLAS™ FFKM” series; the SF grades (the “Products”). The newly developed Products are manufactured entirely without the use of any surfactants*1 or fluorinated polymerization solvents*2. The Products offer high performance equivalent to that of conventional products, while meeting the growing market demand for fluoroelastomers that do not use surfactants or fluorinated polymerization solvents during the manufacturing process. This has been achieved through AGC’s innovative, proprietary polymer manufacturing technology (Surfactant-Free & Fluoro Solvent-Free Technology, hereafter the “Technology”). Initially, this Technology will be applied to the high-temperature-resistant type of FFKM fluoroelastomers and new grades
Andersen Consulting udvider platformen med tilføjelsen af HTP Group17.7.2025 18:46:00 CEST | Pressemeddelelse
Andersen Consulting fortsætter med at udvide sin konsulentkapacitet med tilføjelsen af samarbejdsfirmaet Hoffman Talent Partners (HTP Group), et executive search- og konsulentfirma med hovedkvarter i Bruxelles, Belgien. HTP Group hjælper med at frembringe indflydelsesrige ledere til morgendagens organisationer. HTP formidler arbejdskraft ved hjælp af executive search, midlertidige stillinger og as-a-service-modeller sideløbende med ledelses- og it-konsulenttjenester. HTP Group opererer gennem tre enheder: Hightech Partners, som specialiserer sig i executive search og ledelsesrådgivning til virksomheder, der er aktive inden for digital transformation, Hoffman & Associates, som fokuserer på executive search og interim management på tværs af sektorer og funktioner på bestyrelses- og direktionsniveau, og Ataya & Partners, som fokuserer på digital governance og yder rådgivning inden for cybersikkerhed og databeskyttelse. "Organisationer under forandring har brug for ledelse, der kan holde t
Dubai Launches World’s First Icon Classification for Human–Machine Collaboration in Research and Publications17.7.2025 18:40:00 CEST | Press release
Classification system sets new standard for transparency in the age of AI-assisted knowledge creation Dubai has launched the world’s first icon-based classification system to represent the level of human–machine collaboration in the process of producing research, publications, and public-facing content. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717193317/en/ Dubai launches world’s first icon classification for Human–Machine Collaboration in research and publications (Infographic: AETOSWire) Developed by the Dubai Future Foundation (DFF), the Human–Machine Collaboration (HMC) Icons offer a new global standard for transparency, clearly indicating the extent to which humans and AI worked together throughout the creation process. The classification is free to use, copyrighted for consistency, and openly available for researchers, publishers, and content creators worldwide. His Highness Sheikh Hamdan bin Mohammed bin Rash
Battery Ventures Promotes Justin Rosner to Partner17.7.2025 15:47:00 CEST | Press release
Battery elevates 11 team members worldwide to bolster its multi-stage investment strategy across software/AI, infrastructure tech and industrial technology Battery Ventures, a global, technology-focused investment firm, today announced nearly a dozen new internal promotions across four offices, including the elevation of Justin Rosner—a specialist in industrial technology and life-science tools—to partner. Battery also named four new principals across its venture-capital and private-equity practices, highlighting the firm’s penchant for promoting talent from within the firm. The new principals are Sudheendra Chilappagari in San Francisco; Michael Hoeksema in New York; Lior Mallul in Tel Aviv; and Lauren Wedell in Boston. Wedell and Mallul both joined Battery in 2018, while Hoeksema joined in 2017. Chilappagari, a former founder and technology product executive, joined the firm in 2021. “These promotions highlight Battery’s continued, global investment focus, even in the face of macroec
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum